Episode 3: Telehealth Obesity Medicine and the Death of Diet Culture

Release Date:

Send us a textResources for the Community:___________________________________________________________________Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Ro GLP-1 Insurance Checker https://ro.co/weight-loss/glp1-insurance-checker/Ro GLP-1 Supply and Shortage Tracker https://ro.co/weight-loss/supply-tracker/Learn more about Obesity https://www.obesityaction.org/ ______________________________________________________________________We had some technical difficulties this week, so the audio isn't the best. We discuss the traumatic damage that diet culture causes those who are obese because they keep being told it's their fault, while many of them had a metabolic condition all along. Dr. Matthea Rentea, MD, a Board Certified Internist and a Diplomate of the American Board of Obesity Medicine joined us to discuss GLP1 medications like Ozempic, Wegovy, Saxsenda, and Mounjaro and how they can be prescribed to aid obese patients to create a healthier lifestyle. We also discuss the rise of obesity telehealth practices. ______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy  Support the showKim Carlos @DMFKimonMounjaro on TikTokKat Carter @KatCarter7 on TikTok

Episode 3: Telehealth Obesity Medicine and the Death of Diet Culture

Title
Episode 3: Telehealth Obesity Medicine and the Death of Diet Culture
Copyright
Release Date

flashback